Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis. Issue 4 (30th April 2023)

Record Type:: Journal Article
Title:: Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis. Issue 4 (30th April 2023)
Main Title:: Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis
Authors:: Canales, Miguel A.
Buchholz, Thomas A.
Bortolini, Jaisson A.P.
Fogliatto, Laura M.
Ishikawa, Takayuki
Izutsu, Koji
Salar, Antonio
Sharman, Jeff P.
Klingbiel, Dirk
Pokala, Sunny
Vorozheikina, Ekaterina
Trask, Peter
Parreira, Joana
Hübel, Kai
Abstract:
Is Part Of:: HemaSphere. Volume 7:Issue 4(2023)
Journal:: HemaSphere
Issue:: Volume 7:Issue 4(2023)
Issue Display:: Volume 7, Issue 4 (2023)
Year:: 2023
Volume:: 7
Issue:: 4
Issue Sort Value:: 2023-0007-0004-0000
Page Start:: e860
Page End:
Publication Date:: 2023-04-30
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000860 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26813.xml